Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Drug-Induced Valvular Heart Disease

Carlos Ceron  1 , Amandeep Goyal  2 , Amgad N. Makaryus  3
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Book

Drug-Induced Valvular Heart Disease

Carlos Ceron et al.

Excerpt

Drug-induced valvular heart disease (DIVHD) is a condition involving changes in the morphology and functionality of valvular leaflets secondary to exposure to various types of medications. DIVHD is mainly diagnosed by echocardiographic changes in the population at risk and was first associated with ergot alkaloids in the mid-1960s after echocardiographic changes were found in patients using these types of medications. It has been well documented that these medications produce the proliferation of valvular interstitial cells and subsequent insufficiency of the heart valves by stimulating 5-HT2B receptors.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Carlos Ceron declares no relevant financial relationships with ineligible companies.

Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies.

Disclosure: Amgad Makaryus declares no relevant financial relationships with ineligible companies.

References

    1. Koshkelashvili N, Kohli P, Linefsky J. Fifty-seven-year-old man with progressive dyspnoea. Heart. 2019 Apr;105(7):544-578. - PubMed
    1. Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM, CAMELLIA–TIMI 61 Steering Committee and Investigators Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. N Engl J Med. 2018 Sep 20;379(12):1107-1117. - PubMed
    1. Manolis AA, Manolis TA, Mikhailidis DP, Manolis AS. Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - part 1. Expert Opin Drug Saf. 2018 Sep;17(9):875-892. - PubMed
    1. Tufano A, Galderisi M, Esposito L, Trimarco V, Sorriento D, Gerusalem G, Picardi M, Lancellotti P, Pane F. Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies. Semin Thromb Hemost. 2018 Jun;44(4):388-396. - PubMed
    1. Rajamannan NM. Fenfluramine-Phentermine is Associated with an Increase in Cellular Proliferation Ex Vivo and In Vitro. J Heart Valve Dis. 2017 Jul;26(4):467-471. - PubMed

Publication types